Oramed Pharmaceuticals Inc.

News & Events

Press Releases

In The Media

1. Alpha Tau Announces Closing of $36.9 Million Registered Direct Offering and Strategic Marketing Alliance with Oramed Pharmaceuticals

   GlobeNewswire APR 28, 2025 9:00 AM EDT
   JERUSALEM, April 28, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “...
   READ ARTICLE

2. Oramed Pharmaceuticals Announces $36.9 Million Investment and Strategic Collaboration with Alpha Tau Medical

   PR Newswire APR 28, 2025 9:00 AM EDT
   Oramed Pharmaceuticals Announces $36.9 Million Investment and Strategic Collaboration with Alpha ...
   READ ARTICLE

3. Oramed Pharmaceuticals Issues Letter to Shareholders

   PR Newswire MAR 4, 2025 9:00 AM EST
   Oramed Pharmaceuticals Issues Letter to Shareholders PR Newswire Key Highligh...
   READ ARTICLE

4. Oramed Announces Transformative Joint Venture to Accelerate Development and Commercialization of Oral Insulin

   PR Newswire FEB 11, 2025 9:15 AM EST
   Oramed Announces Transformative Joint Venture to Accelerate Development and Commercialization of ...
   READ ARTICLE

5. Oramed Announces Oravax's Oral COVID-19 Vaccine Has Received South African Approval to Initiate Phase 1 Trial

   Canada Newswire OCT 29, 2021 7:25 AM EDT
   Oramed Announces Oravax's Oral COVID-19 Vaccine Has Received South African Approval to In...
   READ ARTICLE

6. Frost & Sullivan Publishes Quarterly Update on Oramed Pharmaceuticals Inc. (NASDAQ/TASE: ORMP) - Oramed has a sufficient cash balance to fund its clinical development timeline in the near term; several clinical milestones are scheduled for 2018 and 2019; stock target price remains at NIS 53.2

   Canada Newswire MAY 9, 2018 6:27 AM EDT
   Frost & Sullivan Publishes Quarterly Update on Oramed Pharmaceuticals Inc. (NASDAQ/TAS...
   READ ARTICLE

7. From the Needle to the Pill: How Biotechnology Breakthough Can Help Patients, Doctors and Insurers Huge Costs

   ACCESS Newswire NOV 7, 2011 7:01 AM EST
   Oramed Pharmaceuticals (OTCBB:ORMP) has developed a platform technology allowing for the oral de...
   READ ARTICLE

8. Oramed Pharmaceuticals Signs Agreement with Encorium Group to Commence Investigational New Drug Application

   Canada Newswire JUN 19, 2007 8:59 AM EDT
   READ ARTICLE

9. Exclusive Interview with Oramed Pharmaceuticals Inc. CEO, Nadav Kidron on www.CEOcast.com

   Canada Newswire JUN 6, 2007 8:58 AM EDT
   READ ARTICLE

10. Oramed Pharmaceuticals Begins Phase 1 Human Clinical Trials

    Canada Newswire MAY 8, 2007 10:10 AM EDT
    READ ARTICLE